MEMPHIS, Tenn., Nov. 19, 2015 /PRNewswire/ -- Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback